Skip to Content
Connected health research - web banner

Connected health research

Report from the Capgemini Research Institute

Healthcare is undergoing a profound transformation driven by connected technology. The Capgemini Research Institute’s report, “The connected health revolution,” reveals the unprecedented opportunities that arise from connected health.

Based on a survey of 420 industry executives from biotechnology, pharmaceutical, and MedTech organizations, this comprehensive study provides a unique insight into the adoption and maturity of connected health initiatives. The results are striking: 63% of life sciences organizations have connected health products already on the market or under development, with nearly 20% of biopharma organizations having rolled out connected health offerings – a sixfold increase from 2021.

The report highlights the growing importance of connected health, with organizations anticipating an average contribution of 22% to their total revenue by 2028. This shift is fueled by the increasing adoption of digital health solutions, such as telemedicine platforms, clinical decision-support systems, and wearable technologies, which are revolutionizing patient care and generating new revenue streams.

The integration of generative AI technologies also offers tremendous potential benefits, including improved patient support, tailored personalized care, and increased operational efficiency.

However, our research also identifies key challenges that must be addressed to harness the full potential of connected health. These include strategy, governance, funding, technology integration, data management, regulations, and talent.

To overcome these hurdles, we propose seven practical recommendations for life sciences organizations to deliver a successful connected health portfolio:

  • Define and articulate your vision and value proposition for connected health 
  • Design digital product offerings that deliver the proposed value 
  • Design/develop scalable, secure, and compliant data infrastructure and operations 
  • Enhance capabilities in digital, engineering, and human-centric design 
  • Engage with partners, alliances, and early-stage innovators to share expertise and capabilities 
  • Take measures to bridge the talent gap 
  • Establish robust quality assurance processes to ensure regulatory compliance. 

Download The connected health revolution to gain a deeper understanding of the opportunities and challenges shaping the future of healthcare.

Stay informed

Subscribe to have the latest reports from the Capgemini Research Institute delivered direct to your inbox.

Meet our experts

Thorsten Rall

Global Industry Lead Life Sciences, EVP
Since January 2023, Thorsten has been the Executive Vice President and Global Industry Lead for Life Sciences at Capgemini. Previously, he worked at Novartis in various senior roles. As Senior Vice President of Digital Transformation & Innovation, he led the digital function, developed and implemented high-risk, high-return strategic innovation initiatives, and was responsible for Business Development and partnerships in the digital space.

Geoff McCleary

Vice President, Global Connected Health Lead, Capgemini
As the VP Global Connected Health Lead at Capgemini, I help healthcare and life sciences leaders turn their connected health efforts into value-driving enterprises. I have over 25 years of experience in leading digital innovation, strategy, and marketing for global clients across the health ecosystem, from pharma and biotech to providers and payers.

Ross Landles

Vice President, Innovation Strategy & Design, frog

Abhishek Khandelwal

Vice President, Engineering and R&D Services, Capgemini Engineering

Suresh Sarojani

CTO MedTech, Capgemini Engineering

Ramya Krishna Puttur

Expert in Analytics and Strategy, Digital Transformation, Innovation